← Back to Search

Hormone Therapy

Rehumanized Intervention for Self-Harm

N/A

Waitlist Available

Research Sponsored by Florida State University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Between the ages of 18 and 40

Biological females with a regular menstrual cycle of 26-30 days

Must not have

Medical conditions precluding engagement in a 10-hour fast (consumption of water allowed)

Life-threatening suicide risk requiring appropriate safety measures (e.g., hospitalization)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up this measure will be collected at baseline and after the experiment (approximately 30 minutes later).

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to investigate if feeling less human is a risk factor for suicide. The researchers will use a new method to help participants feel more human and compare them to a control group to see if it

Who is the study for?

This trial is for individuals experiencing self-harm thoughts or behaviors, who are undergoing rehabilitation and treatment. Specific eligibility criteria details were not provided, so it's unclear who exactly can participate.

What is being tested?

The study tests a new 'rehumanized' intervention aimed at reducing self-dehumanization against a control group to see if it affects suicidal ideation and oxytocin levels in the blood.

What are the potential side effects?

Since this trial involves clinical interviews, interventions through conversation or activities, self-report measures, and blood draws, side effects may include discomfort from discussing personal experiences and minor pain or bruising from blood draws.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 18 and 40 years old.

Select...

I am a woman with a regular menstrual cycle lasting 26-30 days.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I cannot fast for 10 hours due to a health condition.

Select...

I am at a high risk of suicide and may need hospital care for safety.

Select...

I have been diagnosed with a psychosis-related condition.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ this measure will be collected at baseline and after the experiment (approximately 30 minutes later). then, suicidal ideation will be collected again 1 month later.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~this measure will be collected at baseline and after the experiment (approximately 30 minutes later). then, suicidal ideation will be collected again 1 month later.

This trial's timeline: 3 weeks for screening, Varies for treatment, and this measure will be collected at baseline and after the experiment (approximately 30 minutes later). then, suicidal ideation will be collected again 1 month later. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change in Oxytocin Levels

Change in Suicidal Ideation

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Rehumanized InterventionExperimental Treatment4 Interventions

This self-rehumanization intervention will involve a set of multi-sensory activities (i.e., reading, writing, and speaking) to prompt body and soul awareness, agency, connection, and creativity.

Group II: Control InterventionActive Control4 Interventions

Control Intervention about political attitudes

0 / 5Eligibility criteria met